On the other hand, deletion and/or neutralization of Dkk3 in TCR/MHC class-I double transgenic mice increases local CD8+ T cell infiltration and enhances MHC class-I mismatched anti-tumor and skin graft rejection [79]. The gene discussed is CD8A; the disease is neoplasm.